Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Nat Protoc. 2022 Aug 8;17(11):2431–2468. doi: 10.1038/s41596-022-00724-4
Component Amount (μL) Final concentration
Annealed spacer oligonucleotides, 1μM
Golden Gate part 1 (from Step 3Aiv)
1 μl 0.1 μM
Annealed and phosphorylated sgRNA scaffold oligonucleotides, 1μM
Golden Gate part 2 (from Step 3Aiv or 3Avi)
1 μl 0.1 μM
Annealed epegRNA RTT/PBS 3′ extension oligonucleotides, 1μM
Golden Gate part 3 (from Step 3Aiv)
1 μl 0.1 μM
pU6-tevopreq1-GG-acceptor 2.2 kb fragment, 30ng / μl
Golden Gate part 4 (from Step 3Axii)
1 μl 3 ng / μl
BsaI-HFv2 (20U / μl) 0.2 μl 0.4 U/μl
NcoI-HF (20U / μl) 0.2 μl 0.4 U/μl
PvuII-HF (20U / μl) 0.2 μl 0.4 U/μl
T4 DNA ligase (40U / μl) 0.50 μl 2 U/μl
10× T4 DNA ligase buffer 1 μl
Nuclease-free H20 3.9 μl -
Total reaction volume 10 μl -